10 Centers Share First Avon ‘Progress for Patients’ Grants

Publication
Article
Oncology NEWS InternationalOncology NEWS International Vol 11 No 12
Volume 11
Issue 12

BETHESDA, Maryland-Six initial breast cancer research grants totaling $2.5 million have been awarded through the National Cancer Institute-Avon Foundation’s Progress for Patients program to fund innovative translational science at 10 research institutions. The program administers a $20 million pledge from the Avon Foundation. The initial grants consist of $1.99 million from the Avon Foundation and $660,000 from NCI.

BETHESDA, Maryland—Six initial breast cancer research grants totaling $2.5 million have been awarded through the National Cancer Institute-Avon Foundation’s Progress for Patients program to fund innovative translational science at 10 research institutions. The program administers a $20 million pledge from the Avon Foundation. The initial grants consist of $1.99 million from the Avon Foundation and $660,000 from NCI.

Lead institutions for the six grants are the University of Alabama, Baylor College of Medicine, Fred Hutchinson Cancer Center, University of North Carolina at Chapel Hill, Duke University, and Dana Farber-Harvard Cancer Institute.

Newsletter

Stay up to date on recent advances in the multidisciplinary approach to cancer.

Recent Videos
Event-free survival benefit was observed among BCG-naïve patients with carcinoma in situ undergoing treatment with sasanlimab plus BCG.
Specialties including neurosurgery, radiation oncology, and neuro-rehabilitation all play a notable role in the care of patients with brain tumors.
Related Content